{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:12:13Z","timestamp":1791493933187,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C108-003, TSGH-B-109010"],"award-info":[{"award-number":["TSGH-C108-003, TSGH-B-109010"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the safety of using fluoroquinolones in pediatric population in Taiwan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients aged 0~18\u2009years old with fluoroquinolones prescriptions \u22655 consecutive days during year 2000 to 2013 were selected from the National Health Insurance Research Database, 4-time case number were selected as controls. We evaluated the patient\u2019s outcome after the use of fluoroquinolones by reviewing a newly diagnosis of the following collagen-associated adverse events by International Classification of Diseases, Ninth Revision, Clinical Modification codes, covering tendons rupture, retinal detachments, gastrointestinal tract perforation, aortic aneurysm or dissection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the enrolled patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009167,105), collagen-associated adverse effects developed in 85 cases (0.051%) in 6-month tracking, including 0.051% in the fluoroquinolones study cohort (17 in 33,421) and 0.051% (68 in 133,684) in the fluoroquinolones free comparison cohort. The crude hazard ratio for collagen-associated adverse events in the fluoroquinolones group was 0.997 (0.586\u20131.696;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.990). After adjusting for age, sex, catastrophic illness, low-income household, seasons, levels of urbanization, and healthcare, the corrected hazard ratio in 6-month tracking with FQs was 1.330 (95% CI; 0.778\u20132.276;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.255).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is no significant difference of collagen-associated adverse effects between fluoroquinolones group and fluoroquinolones free group from our data. We propose that fluoroquinolones for pediatric population in clinical practice may be not so harmful as previous references reported.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-020-1962-0","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T02:02:20Z","timestamp":1581386540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan"],"prefix":"10.1186","volume":"20","author":[{"given":"Pei-Han","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Fen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-An","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-0780","authenticated-orcid":false,"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"issue":"Suppl B","key":"1962_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jac\/26.suppl_B.41","volume":"26","author":"H Lode","year":"1990","unstructured":"Lode H, Hoffken G, Boeckk M, Deppermann N, Borner K, Koeppe P. Quinolone pharmacokinetics and metabolism. J Antimicrob Chemother. 1990;26(Suppl B):41\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"4a","key":"1962_CR2","doi-asserted-by":"publisher","first-page":"26s","DOI":"10.1016\/0002-9343(92)90304-T","volume":"92","author":"TG Mant","year":"1992","unstructured":"Mant TG. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing. Am J Med. 1992;92(4a):26s\u201332s.","journal-title":"Am J Med"},{"issue":"11","key":"1962_CR3","doi-asserted-by":"publisher","first-page":"e010077","DOI":"10.1136\/bmjopen-2015-010077","volume":"5","author":"N Daneman","year":"2015","unstructured":"Daneman N, Lu H, Redelmeier DA. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open. 2015;5(11):e010077.","journal-title":"BMJ Open"},{"issue":"9","key":"1962_CR4","doi-asserted-by":"publisher","first-page":"e0183813","DOI":"10.1371\/journal.pone.0183813","volume":"12","author":"SC Hsu","year":"2017","unstructured":"Hsu SC, Chang SS, Lee MG, Lee SH, Tsai YW, Lin SC, et al. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: an analysis of nationally representative cohort. PLoS One. 2017;12(9):e0183813.","journal-title":"PLoS One"},{"issue":"13","key":"1962_CR5","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2012.383","volume":"307","author":"M Etminan","year":"2012","unstructured":"Etminan M, Forooghian F, Brophy JM, Bird ST, Maberley D. Oral fluoroquinolones and the risk of retinal detachment. JAMA. 2012;307(13):1414\u20139.","journal-title":"JAMA"},{"issue":"9","key":"1962_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40264-013-0089-8","volume":"36","author":"AL Stephenson","year":"2013","unstructured":"Stephenson AL, Wu W, Cortes D, Rochon PA. Tendon injury and fluoroquinolone use: a systematic review. Drug Saf. 2013;36(9):709\u201321.","journal-title":"Drug Saf"},{"key":"1962_CR7","doi-asserted-by":"publisher","first-page":"k678","DOI":"10.1136\/bmj.k678","volume":"360","author":"B Pasternak","year":"2018","unstructured":"Pasternak B, Inghammar M, Svanstrom H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018;360:k678.","journal-title":"BMJ"},{"issue":"1","key":"1962_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tox.2005.04.002","volume":"212","author":"J Sendzik","year":"2005","unstructured":"Sendzik J, Shakibaei M, Schafer-Korting M, Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology. 2005;212(1):24\u201336.","journal-title":"Toxicology"},{"issue":"3","key":"1962_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0002-9610(84)90179-X","volume":"147","author":"EM Sykes Jr","year":"1984","unstructured":"Sykes EM Jr. Colon perforation in Ehlers-Danlos syndrome. Report of two cases and review of the literature. Am J Surg. 1984;147(3):410\u20133.","journal-title":"Am J Surg"},{"issue":"3","key":"1962_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10016-001-0229-y","volume":"16","author":"DP Germain","year":"2002","unstructured":"Germain DP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2002;16(3):391\u20137.","journal-title":"Ann Vasc Surg"},{"key":"1962_CR11","unstructured":"Administration. USFaD. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics.\u00a0Accessed 21 Dec 2018."},{"key":"1962_CR12","unstructured":"Administration. USFaD. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics.\u00a0Accessed 8 May 2018."},{"issue":"5","key":"1962_CR13","doi-asserted-by":"publisher","first-page":"e20162706","DOI":"10.1542\/peds.2016-2706","volume":"138","author":"Mary Anne Jackson","year":"2016","unstructured":"Jackson MA, Schutze GE. The use of systemic and topical fluoroquinolones. Pediatrics. 2016;138(5). https:\/\/doi.org\/10.1542\/peds.2016-2706.","journal-title":"Pediatrics"},{"key":"1962_CR14","unstructured":"Pediatric Infectious Diseases Society of Taiwan CHRC, National Health Research Institutes. Recommendations for the Use of New Quinolone Antibiotics in Children. Available from: http:\/\/www.pids.org.tw\/index.php?route=news\/news_detail&news_id=91. Accessed 20 Feb 2012."},{"issue":"9","key":"1962_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jcph.715","volume":"56","author":"K Patel","year":"2016","unstructured":"Patel K, Goldman JL. Safety concerns surrounding quinolone use in children. J Clin Pharmacol. 2016;56(9):1060\u201375.","journal-title":"J Clin Pharmacol"},{"key":"1962_CR16","volume-title":"The prescribing pattern of Fluoroquinolone in pediatric patients in Taiwan","author":"FH Yi","year":"2013","unstructured":"Yi FH. The prescribing pattern of Fluoroquinolone in pediatric patients in Taiwan. Tainan City: National Cheng Kung University; 2013."},{"key":"1962_CR17","unstructured":"Pediatric Infectious Diseases Society of Taiwan CHRC, National Health Research Institutes. Recommendations for the diagnosis and management of acute otitis media in children. Available from: http:\/\/www.pids.org.tw\/index.php?route=news\/news_detail&news_id=96.\u00a0Accessed 1 Oct 2016."},{"issue":"11","key":"1962_CR18","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","volume":"175","author":"CC Lee","year":"2015","unstructured":"Lee CC, Lee MT, Chen YS, Lee SH, Chen YS, Chen SC, et al. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Intern Med. 2015;175(11):1839\u201347.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1962_CR19","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1093\/jpids\/piy056","volume":"7","author":"A Dixit","year":"2018","unstructured":"Dixit A, Karandikar MV, Jones S, Nakamura MM. Safety and tolerability of Moxifloxacin in children. J Pediatric Infect Dis Soc. 2018;7(3):e92\u2013e101.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"5","key":"1962_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3345\/kjp.2013.56.5.196","volume":"56","author":"S-H Choi","year":"2013","unstructured":"Choi S-H, Kim EY, Kim Y-J. Systemic use of fluoroquinolone in children. Korean J Pediatr. 2013;56(5):196\u2013201.","journal-title":"Korean J Pediatr"},{"key":"1962_CR21","doi-asserted-by":"publisher","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","volume":"40","author":"L-Y Lin","year":"2018","unstructured":"Lin L-Y, Warren-Gash C, Smeeth L, Chen P-C. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2018;40:e2018062.","journal-title":"Epidemiol Health"},{"key":"1962_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"C-Y Hsieh","year":"2019","unstructured":"Hsieh C-Y, Su C-C, Shao S-C, Sung S-F, Lin S-J, Kao Yang Y-H, et al. Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"issue":"5","key":"1962_CR23","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3748\/wjg.v22.i5.1877","volume":"22","author":"S Cardile","year":"2016","unstructured":"Cardile S, Martinelli M, Barabino A, Gandullia P, Oliva S, Di Nardo G, et al. Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children. World J Gastroenterol. 2016;22(5):1877\u201383.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1962_CR24","doi-asserted-by":"publisher","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","volume":"4","author":"S Narum","year":"2014","unstructured":"Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4(5):e004587.","journal-title":"BMJ Open"},{"issue":"5","key":"1962_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/cxo.12667","volume":"101","author":"K Tekin","year":"2018","unstructured":"Tekin K, Inanc M, Kurnaz E, Bayramoglu E, Aydemir E, Koc M, et al. Quantitative evaluation of early retinal changes in children with type 1 diabetes mellitus without retinopathy. Clin Exp Optom. 2018;101(5):680\u20135.","journal-title":"Clin Exp Optom"},{"issue":"10","key":"1962_CR26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1097\/HJH.0b013e3282f051b4","volume":"25","author":"E Lurbe","year":"2007","unstructured":"Lurbe E. Hypertension and target organ damage in children and adolescents. J Hypertens. 2007;25(10):1998\u20132000.","journal-title":"J Hypertens"},{"key":"1962_CR27","doi-asserted-by":"publisher","unstructured":"Leone O, Corsini A, Pacini D, Corti B, Lorenzini M, Laus V, et al. The complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2019. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.08.108.","DOI":"10.1016\/j.jtcvs.2019.08.108"},{"key":"1962_CR28","unstructured":"Administration. USFaD. FDA updates warnings for fluoroquinolone antibiotics. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-warnings-fluoroquinolone-antibiotics.\u00a0Accessed 15 Aug 2016."},{"issue":"2","key":"1962_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jmii.2015.05.016","volume":"49","author":"CT Wu","year":"2016","unstructured":"Wu CT, Lee HY, Chen CL, Tuan PL, Chiu CH. High prevalence and antimicrobial resistance of urinary tract infection isolates in febrile young children without localizing signs in Taiwan. J Microbiol Immunol Infect. 2016;49(2):243\u20138.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"1962_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/emj.20.1.54","volume":"20","author":"CJ Mann","year":"2003","unstructured":"Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54\u201360.","journal-title":"Emerg Med J"},{"issue":"6","key":"1962_CR31","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/PRS.0b013e3181f44abc","volume":"126","author":"JW Song","year":"2010","unstructured":"Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010;126(6):2234\u201342.","journal-title":"Plast Reconstr Surg"},{"issue":"9147","key":"1962_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","volume":"353","author":"DM Lloyd-Jones","year":"1999","unstructured":"Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89\u201392.","journal-title":"Lancet"},{"issue":"25","key":"1962_CR33","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.114.010890","volume":"130","author":"D Sidloff","year":"2014","unstructured":"Sidloff D, Choke E, Stather P, Bown M, Thompson J, Sayers R. Mortality from thoracic aortic diseases and associations with cardiovascular risk factors. Circulation. 2014;130(25):2287\u201394.","journal-title":"Circulation"},{"issue":"9735","key":"1962_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"issue":"5","key":"1962_CR35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jacc.2005.09.065","volume":"47","author":"SP Marso","year":"2006","unstructured":"Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47(5):921\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1962_CR36","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/01.idc.0000230544.11499.8b","volume":"14","author":"P Kardas","year":"2006","unstructured":"Kardas P. Noncompliance in current antibiotic practice. Infect Dis Clin Pract. 2006;14(4):S11\u2013S4.","journal-title":"Infect Dis Clin Pract"},{"issue":"1","key":"1962_CR37","first-page":"53","volume":"38","author":"C Chen","year":"2005","unstructured":"Chen C, Chen YM, Hwang KL, Lin SJ, Yang CC, Tsay RW, et al. Behavior, attitudes and knowledge about antibiotic usage among residents of Changhua. Taiwan J Microbiol Immunol Infect. 2005;38(1):53\u20139.","journal-title":"Taiwan J Microbiol Immunol Infect"},{"issue":"4","key":"1962_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11739-015-1213-9","volume":"10","author":"C Mazzali","year":"2015","unstructured":"Mazzali C, Duca P. Use of administrative data in healthcare research. Intern Emerg Med. 2015;10(4):517\u201324.","journal-title":"Intern Emerg Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-1962-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-020-1962-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-1962-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T19:50:26Z","timestamp":1612900226000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-1962-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-1962-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17934\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17934\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17934\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted following the Code of Ethics of the World Medical Association (Declaration of Helsinki). The Institutional Review Board of Tri-Service General Hospital approved this study and waived the need for individual written informed consent because all participants\u2019 ID was removed or properly concealed (TSGH IRB No.2\u2013105\u201305-082).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}